Skip to content

    Heart Failure Health Center

    Font Size
    A
    A
    A

    Digitek Tablets Recalled

    All Lots of Digitek Tablets Sold Under the Labels "Bertek" and "UDL" Recalled Because of Possible Double Dose
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    April 28, 2008 -- All lots of Digitek tablets distributed by Mylan Pharmaceuticals and sold under the labels "Bertek" or "UDL" are being recalled because they may contain a dangerous double dose of their active ingredient.

    Digitek pills are used to treat heart failure and abnormal heart rhythms. The company Actavis Totowa makes the recalled Digitek pills.

    "Tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than is appropriate," states an Actavis Totowa news release posted on the FDA's web site.

    Double-strength tablets pose a risk of digitalis toxicity, which can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, slow heart rate, and death. Actavis Totowa says it has received "several reports of illness and injuries."

    Patients with medical questions should contact their health care provider. For other information, call the Mylan recall line at (888) 276-6166 Monday through Friday, from 8 a.m to 5 p.m. Eastern time, or visit the Actavis web site.

    To report side effects to the FDA, call 800-FDA-1088 or visit the FDA's MedWatch web site.

    Today on WebMD

    Compressed heart
    Article
    Salt Shockers
    Slideshow
     
    Inside A Heart Attack
    Slideshow
    lowering blood pressure
    SLIDESHOW
     

    Mechanical Heart
    Article
    Omega 3 Overview Slideshow
    Slideshow
     
    Atrial Fibrillation Guide
    Slideshow
    Simple Steps to Lower Cholesterol
    Slideshow
     

    Compressed heart
    Article
    FAQ Heart Failure
    Article
     
    Cholesterol Confusion
    Health Check
    Resolved To Quit Smoking
    Slideshow
     

    WebMD Special Sections